nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Estropipate—osteoporosis	0.0924	0.274	CbGbCtD
Maprotiline—ABCB1—Ethinyl Estradiol—osteoporosis	0.0521	0.154	CbGbCtD
Maprotiline—CYP1A2—Conjugated Estrogens—osteoporosis	0.0437	0.13	CbGbCtD
Maprotiline—CYP2D6—Cholecalciferol—osteoporosis	0.0392	0.116	CbGbCtD
Maprotiline—CYP1A2—Estradiol—osteoporosis	0.0384	0.114	CbGbCtD
Maprotiline—ABCB1—Conjugated Estrogens—osteoporosis	0.0382	0.113	CbGbCtD
Maprotiline—ABCB1—Estradiol—osteoporosis	0.0336	0.0994	CbGbCtD
Maprotiline—Gastrointestinal pain—Calcitriol—osteoporosis	0.000619	0.00113	CcSEcCtD
Maprotiline—Abdominal pain—Raloxifene—osteoporosis	0.000617	0.00113	CcSEcCtD
Maprotiline—Body temperature increased—Raloxifene—osteoporosis	0.000617	0.00113	CcSEcCtD
Maprotiline—Vision blurred—Conjugated Estrogens—osteoporosis	0.000615	0.00112	CcSEcCtD
Maprotiline—Urticaria—Ibandronate—osteoporosis	0.000614	0.00112	CcSEcCtD
Maprotiline—Body temperature increased—Ibandronate—osteoporosis	0.000611	0.00111	CcSEcCtD
Maprotiline—Abdominal pain—Ibandronate—osteoporosis	0.000611	0.00111	CcSEcCtD
Maprotiline—Confusional state—Pamidronate—osteoporosis	0.00061	0.00111	CcSEcCtD
Maprotiline—Syncope—Zoledronate—osteoporosis	0.000608	0.00111	CcSEcCtD
Maprotiline—Leukopenia—Zoledronate—osteoporosis	0.000606	0.00111	CcSEcCtD
Maprotiline—Oedema—Pamidronate—osteoporosis	0.000605	0.0011	CcSEcCtD
Maprotiline—Infection—Pamidronate—osteoporosis	0.000601	0.0011	CcSEcCtD
Maprotiline—Urticaria—Calcitriol—osteoporosis	0.000601	0.0011	CcSEcCtD
Maprotiline—Hepatitis—Estradiol—osteoporosis	0.0006	0.00109	CcSEcCtD
Maprotiline—Palpitations—Zoledronate—osteoporosis	0.000599	0.00109	CcSEcCtD
Maprotiline—Abdominal pain—Calcitriol—osteoporosis	0.000598	0.00109	CcSEcCtD
Maprotiline—Body temperature increased—Calcitriol—osteoporosis	0.000598	0.00109	CcSEcCtD
Maprotiline—Hypoaesthesia—Estradiol—osteoporosis	0.000597	0.00109	CcSEcCtD
Maprotiline—Shock—Pamidronate—osteoporosis	0.000596	0.00109	CcSEcCtD
Maprotiline—Loss of consciousness—Zoledronate—osteoporosis	0.000595	0.00109	CcSEcCtD
Maprotiline—Nervous system disorder—Pamidronate—osteoporosis	0.000594	0.00108	CcSEcCtD
Maprotiline—Thrombocytopenia—Pamidronate—osteoporosis	0.000593	0.00108	CcSEcCtD
Maprotiline—Urinary tract disorder—Estradiol—osteoporosis	0.000592	0.00108	CcSEcCtD
Maprotiline—Vomiting—Etidronic acid—osteoporosis	0.000592	0.00108	CcSEcCtD
Maprotiline—Tachycardia—Pamidronate—osteoporosis	0.000591	0.00108	CcSEcCtD
Maprotiline—Urethral disorder—Estradiol—osteoporosis	0.000588	0.00107	CcSEcCtD
Maprotiline—Rash—Etidronic acid—osteoporosis	0.000587	0.00107	CcSEcCtD
Maprotiline—Convulsion—Zoledronate—osteoporosis	0.000587	0.00107	CcSEcCtD
Maprotiline—Dermatitis—Etidronic acid—osteoporosis	0.000587	0.00107	CcSEcCtD
Maprotiline—Hyperhidrosis—Pamidronate—osteoporosis	0.000585	0.00107	CcSEcCtD
Maprotiline—Syncope—Conjugated Estrogens—osteoporosis	0.000585	0.00107	CcSEcCtD
Maprotiline—Hypertension—Zoledronate—osteoporosis	0.000585	0.00107	CcSEcCtD
Maprotiline—Headache—Etidronic acid—osteoporosis	0.000583	0.00107	CcSEcCtD
Maprotiline—Asthenia—Estropipate—osteoporosis	0.000578	0.00106	CcSEcCtD
Maprotiline—Palpitations—Conjugated Estrogens—osteoporosis	0.000576	0.00105	CcSEcCtD
Maprotiline—Insomnia—Risedronate—osteoporosis	0.000576	0.00105	CcSEcCtD
Maprotiline—Anxiety—Zoledronate—osteoporosis	0.000575	0.00105	CcSEcCtD
Maprotiline—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000573	0.00105	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000573	0.00105	CcSEcCtD
Maprotiline—Paraesthesia—Risedronate—osteoporosis	0.000572	0.00104	CcSEcCtD
Maprotiline—Pruritus—Estropipate—osteoporosis	0.00057	0.00104	CcSEcCtD
Maprotiline—Asthenia—Alendronate—osteoporosis	0.000569	0.00104	CcSEcCtD
Maprotiline—Erythema multiforme—Estradiol—osteoporosis	0.000567	0.00104	CcSEcCtD
Maprotiline—Hypotension—Pamidronate—osteoporosis	0.000566	0.00103	CcSEcCtD
Maprotiline—Convulsion—Conjugated Estrogens—osteoporosis	0.000565	0.00103	CcSEcCtD
Maprotiline—Dry mouth—Zoledronate—osteoporosis	0.000564	0.00103	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000564	0.00103	CcSEcCtD
Maprotiline—Fatigue—Ethinyl Estradiol—osteoporosis	0.000563	0.00103	CcSEcCtD
Maprotiline—Pruritus—Alendronate—osteoporosis	0.000561	0.00102	CcSEcCtD
Maprotiline—Dyspepsia—Risedronate—osteoporosis	0.000561	0.00102	CcSEcCtD
Maprotiline—Eye disorder—Estradiol—osteoporosis	0.00056	0.00102	CcSEcCtD
Maprotiline—Tinnitus—Estradiol—osteoporosis	0.000559	0.00102	CcSEcCtD
Maprotiline—Constipation—Ethinyl Estradiol—osteoporosis	0.000559	0.00102	CcSEcCtD
Maprotiline—Confusional state—Zoledronate—osteoporosis	0.000558	0.00102	CcSEcCtD
Maprotiline—Cardiac disorder—Estradiol—osteoporosis	0.000557	0.00102	CcSEcCtD
Maprotiline—Flushing—Estradiol—osteoporosis	0.000557	0.00102	CcSEcCtD
Maprotiline—Asthenia—Ibandronate—osteoporosis	0.000554	0.00101	CcSEcCtD
Maprotiline—Anxiety—Conjugated Estrogens—osteoporosis	0.000553	0.00101	CcSEcCtD
Maprotiline—Nausea—Etidronic acid—osteoporosis	0.000553	0.00101	CcSEcCtD
Maprotiline—Oedema—Zoledronate—osteoporosis	0.000553	0.00101	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000552	0.00101	CcSEcCtD
Maprotiline—Diarrhoea—Estropipate—osteoporosis	0.000551	0.00101	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Risedronate—osteoporosis	0.00055	0.001	CcSEcCtD
Maprotiline—Infection—Zoledronate—osteoporosis	0.000549	0.001	CcSEcCtD
Maprotiline—Fatigue—Risedronate—osteoporosis	0.000549	0.001	CcSEcCtD
Maprotiline—Insomnia—Pamidronate—osteoporosis	0.000548	0.000999	CcSEcCtD
Maprotiline—Pruritus—Ibandronate—osteoporosis	0.000547	0.000998	CcSEcCtD
Maprotiline—Constipation—Risedronate—osteoporosis	0.000545	0.000994	CcSEcCtD
Maprotiline—Angiopathy—Estradiol—osteoporosis	0.000544	0.000993	CcSEcCtD
Maprotiline—Shock—Zoledronate—osteoporosis	0.000544	0.000993	CcSEcCtD
Maprotiline—Paraesthesia—Pamidronate—osteoporosis	0.000544	0.000992	CcSEcCtD
Maprotiline—Diarrhoea—Alendronate—osteoporosis	0.000543	0.000991	CcSEcCtD
Maprotiline—Asthenia—Calcitriol—osteoporosis	0.000543	0.000991	CcSEcCtD
Maprotiline—Nervous system disorder—Zoledronate—osteoporosis	0.000542	0.00099	CcSEcCtD
Maprotiline—Thrombocytopenia—Zoledronate—osteoporosis	0.000541	0.000988	CcSEcCtD
Maprotiline—Mediastinal disorder—Estradiol—osteoporosis	0.000541	0.000987	CcSEcCtD
Maprotiline—Tachycardia—Zoledronate—osteoporosis	0.00054	0.000985	CcSEcCtD
Maprotiline—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000538	0.000982	CcSEcCtD
Maprotiline—Somnolence—Pamidronate—osteoporosis	0.000538	0.000982	CcSEcCtD
Maprotiline—Skin disorder—Zoledronate—osteoporosis	0.000537	0.00098	CcSEcCtD
Maprotiline—Pruritus—Calcitriol—osteoporosis	0.000535	0.000977	CcSEcCtD
Maprotiline—Hyperhidrosis—Zoledronate—osteoporosis	0.000535	0.000976	CcSEcCtD
Maprotiline—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000534	0.000975	CcSEcCtD
Maprotiline—Diarrhoea—Raloxifene—osteoporosis	0.000534	0.000975	CcSEcCtD
Maprotiline—Dyspepsia—Pamidronate—osteoporosis	0.000533	0.000973	CcSEcCtD
Maprotiline—Dizziness—Estropipate—osteoporosis	0.000533	0.000973	CcSEcCtD
Maprotiline—Oedema—Conjugated Estrogens—osteoporosis	0.000532	0.000972	CcSEcCtD
Maprotiline—Alopecia—Estradiol—osteoporosis	0.00053	0.000967	CcSEcCtD
Maprotiline—Infection—Conjugated Estrogens—osteoporosis	0.000529	0.000966	CcSEcCtD
Maprotiline—Diarrhoea—Ibandronate—osteoporosis	0.000529	0.000965	CcSEcCtD
Maprotiline—Dizziness—Alendronate—osteoporosis	0.000525	0.000958	CcSEcCtD
Maprotiline—Shock—Conjugated Estrogens—osteoporosis	0.000524	0.000956	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000523	0.000954	CcSEcCtD
Maprotiline—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000522	0.000953	CcSEcCtD
Maprotiline—Malnutrition—Estradiol—osteoporosis	0.000522	0.000953	CcSEcCtD
Maprotiline—Fatigue—Pamidronate—osteoporosis	0.000522	0.000953	CcSEcCtD
Maprotiline—Gastrointestinal pain—Risedronate—osteoporosis	0.000521	0.00095	CcSEcCtD
Maprotiline—Tachycardia—Conjugated Estrogens—osteoporosis	0.00052	0.000949	CcSEcCtD
Maprotiline—Urticaria—Ethinyl Estradiol—osteoporosis	0.000519	0.000947	CcSEcCtD
Maprotiline—Constipation—Pamidronate—osteoporosis	0.000518	0.000945	CcSEcCtD
Maprotiline—Diarrhoea—Calcitriol—osteoporosis	0.000518	0.000945	CcSEcCtD
Maprotiline—Skin disorder—Conjugated Estrogens—osteoporosis	0.000517	0.000944	CcSEcCtD
Maprotiline—Hypotension—Zoledronate—osteoporosis	0.000517	0.000943	CcSEcCtD
Maprotiline—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000516	0.000942	CcSEcCtD
Maprotiline—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000516	0.000942	CcSEcCtD
Maprotiline—Dizziness—Raloxifene—osteoporosis	0.000516	0.000942	CcSEcCtD
Maprotiline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000515	0.00094	CcSEcCtD
Maprotiline—Tension—Estradiol—osteoporosis	0.000512	0.000935	CcSEcCtD
Maprotiline—Vomiting—Estropipate—osteoporosis	0.000512	0.000935	CcSEcCtD
Maprotiline—Dysgeusia—Estradiol—osteoporosis	0.000511	0.000933	CcSEcCtD
Maprotiline—Dizziness—Ibandronate—osteoporosis	0.000511	0.000933	CcSEcCtD
Maprotiline—Rash—Estropipate—osteoporosis	0.000508	0.000927	CcSEcCtD
Maprotiline—Dermatitis—Estropipate—osteoporosis	0.000508	0.000927	CcSEcCtD
Maprotiline—Nervousness—Estradiol—osteoporosis	0.000507	0.000926	CcSEcCtD
Maprotiline—Urticaria—Risedronate—osteoporosis	0.000506	0.000923	CcSEcCtD
Maprotiline—Headache—Estropipate—osteoporosis	0.000505	0.000921	CcSEcCtD
Maprotiline—Vomiting—Alendronate—osteoporosis	0.000505	0.000921	CcSEcCtD
Maprotiline—Abdominal pain—Risedronate—osteoporosis	0.000503	0.000919	CcSEcCtD
Maprotiline—Body temperature increased—Risedronate—osteoporosis	0.000503	0.000919	CcSEcCtD
Maprotiline—Rash—Alendronate—osteoporosis	0.0005	0.000913	CcSEcCtD
Maprotiline—Insomnia—Zoledronate—osteoporosis	0.0005	0.000913	CcSEcCtD
Maprotiline—Dermatitis—Alendronate—osteoporosis	0.0005	0.000913	CcSEcCtD
Maprotiline—Feeling abnormal—Pamidronate—osteoporosis	0.000499	0.000911	CcSEcCtD
Maprotiline—Hypotension—Conjugated Estrogens—osteoporosis	0.000498	0.000908	CcSEcCtD
Maprotiline—Headache—Alendronate—osteoporosis	0.000497	0.000908	CcSEcCtD
Maprotiline—Paraesthesia—Zoledronate—osteoporosis	0.000497	0.000906	CcSEcCtD
Maprotiline—Vomiting—Raloxifene—osteoporosis	0.000496	0.000906	CcSEcCtD
Maprotiline—Gastrointestinal pain—Pamidronate—osteoporosis	0.000495	0.000904	CcSEcCtD
Maprotiline—Rash—Raloxifene—osteoporosis	0.000492	0.000898	CcSEcCtD
Maprotiline—Dermatitis—Raloxifene—osteoporosis	0.000492	0.000897	CcSEcCtD
Maprotiline—Somnolence—Zoledronate—osteoporosis	0.000492	0.000897	CcSEcCtD
Maprotiline—Vomiting—Ibandronate—osteoporosis	0.000491	0.000897	CcSEcCtD
Maprotiline—Tremor—Estradiol—osteoporosis	0.000489	0.000893	CcSEcCtD
Maprotiline—Headache—Raloxifene—osteoporosis	0.000489	0.000893	CcSEcCtD
Maprotiline—Rash—Ibandronate—osteoporosis	0.000487	0.000889	CcSEcCtD
Maprotiline—Dermatitis—Ibandronate—osteoporosis	0.000487	0.000888	CcSEcCtD
Maprotiline—Dyspepsia—Zoledronate—osteoporosis	0.000487	0.000888	CcSEcCtD
Maprotiline—Headache—Ibandronate—osteoporosis	0.000484	0.000884	CcSEcCtD
Maprotiline—Insomnia—Conjugated Estrogens—osteoporosis	0.000482	0.000879	CcSEcCtD
Maprotiline—Vomiting—Calcitriol—osteoporosis	0.000481	0.000878	CcSEcCtD
Maprotiline—Agitation—Estradiol—osteoporosis	0.00048	0.000876	CcSEcCtD
Maprotiline—Nausea—Estropipate—osteoporosis	0.000479	0.000874	CcSEcCtD
Maprotiline—Abdominal pain—Pamidronate—osteoporosis	0.000479	0.000874	CcSEcCtD
Maprotiline—Body temperature increased—Pamidronate—osteoporosis	0.000479	0.000874	CcSEcCtD
Maprotiline—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000478	0.000873	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000477	0.000871	CcSEcCtD
Maprotiline—Rash—Calcitriol—osteoporosis	0.000477	0.000871	CcSEcCtD
Maprotiline—Fatigue—Zoledronate—osteoporosis	0.000477	0.00087	CcSEcCtD
Maprotiline—Dermatitis—Calcitriol—osteoporosis	0.000476	0.00087	CcSEcCtD
Maprotiline—Headache—Calcitriol—osteoporosis	0.000474	0.000865	CcSEcCtD
Maprotiline—Somnolence—Conjugated Estrogens—osteoporosis	0.000473	0.000864	CcSEcCtD
Maprotiline—Constipation—Zoledronate—osteoporosis	0.000473	0.000863	CcSEcCtD
Maprotiline—Nausea—Alendronate—osteoporosis	0.000471	0.00086	CcSEcCtD
Maprotiline—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000469	0.000855	CcSEcCtD
Maprotiline—Asthenia—Ethinyl Estradiol—osteoporosis	0.000469	0.000855	CcSEcCtD
Maprotiline—Syncope—Estradiol—osteoporosis	0.000468	0.000855	CcSEcCtD
Maprotiline—Nausea—Raloxifene—osteoporosis	0.000464	0.000846	CcSEcCtD
Maprotiline—Pruritus—Ethinyl Estradiol—osteoporosis	0.000462	0.000843	CcSEcCtD
Maprotiline—Palpitations—Estradiol—osteoporosis	0.000461	0.000842	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00046	0.000839	CcSEcCtD
Maprotiline—Fatigue—Conjugated Estrogens—osteoporosis	0.000459	0.000838	CcSEcCtD
Maprotiline—Nausea—Ibandronate—osteoporosis	0.000459	0.000838	CcSEcCtD
Maprotiline—Loss of consciousness—Estradiol—osteoporosis	0.000459	0.000838	CcSEcCtD
Maprotiline—Asthenia—Risedronate—osteoporosis	0.000457	0.000834	CcSEcCtD
Maprotiline—Feeling abnormal—Zoledronate—osteoporosis	0.000456	0.000832	CcSEcCtD
Maprotiline—Constipation—Conjugated Estrogens—osteoporosis	0.000455	0.000831	CcSEcCtD
Maprotiline—Gastrointestinal pain—Zoledronate—osteoporosis	0.000452	0.000825	CcSEcCtD
Maprotiline—Hypertension—Estradiol—osteoporosis	0.000451	0.000823	CcSEcCtD
Maprotiline—Pruritus—Risedronate—osteoporosis	0.000451	0.000822	CcSEcCtD
Maprotiline—Nausea—Calcitriol—osteoporosis	0.000449	0.00082	CcSEcCtD
Maprotiline—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000447	0.000816	CcSEcCtD
Maprotiline—Anxiety—Estradiol—osteoporosis	0.000443	0.000809	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000441	0.000806	CcSEcCtD
Maprotiline—Urticaria—Zoledronate—osteoporosis	0.000439	0.000802	CcSEcCtD
Maprotiline—Abdominal pain—Zoledronate—osteoporosis	0.000437	0.000798	CcSEcCtD
Maprotiline—Body temperature increased—Zoledronate—osteoporosis	0.000437	0.000798	CcSEcCtD
Maprotiline—Diarrhoea—Risedronate—osteoporosis	0.000436	0.000795	CcSEcCtD
Maprotiline—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000435	0.000795	CcSEcCtD
Maprotiline—Dry mouth—Estradiol—osteoporosis	0.000435	0.000794	CcSEcCtD
Maprotiline—Asthenia—Pamidronate—osteoporosis	0.000434	0.000793	CcSEcCtD
Maprotiline—Dizziness—Ethinyl Estradiol—osteoporosis	0.000432	0.000788	CcSEcCtD
Maprotiline—Confusional state—Estradiol—osteoporosis	0.00043	0.000784	CcSEcCtD
Maprotiline—Pruritus—Pamidronate—osteoporosis	0.000428	0.000782	CcSEcCtD
Maprotiline—Oedema—Estradiol—osteoporosis	0.000426	0.000778	CcSEcCtD
Maprotiline—Infection—Estradiol—osteoporosis	0.000423	0.000773	CcSEcCtD
Maprotiline—Urticaria—Conjugated Estrogens—osteoporosis	0.000423	0.000772	CcSEcCtD
Maprotiline—Dizziness—Risedronate—osteoporosis	0.000421	0.000769	CcSEcCtD
Maprotiline—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000421	0.000768	CcSEcCtD
Maprotiline—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000421	0.000768	CcSEcCtD
Maprotiline—Shock—Estradiol—osteoporosis	0.000419	0.000765	CcSEcCtD
Maprotiline—Nervous system disorder—Estradiol—osteoporosis	0.000418	0.000763	CcSEcCtD
Maprotiline—Tachycardia—Estradiol—osteoporosis	0.000416	0.000759	CcSEcCtD
Maprotiline—Vomiting—Ethinyl Estradiol—osteoporosis	0.000415	0.000758	CcSEcCtD
Maprotiline—Diarrhoea—Pamidronate—osteoporosis	0.000414	0.000756	CcSEcCtD
Maprotiline—Skin disorder—Estradiol—osteoporosis	0.000414	0.000756	CcSEcCtD
Maprotiline—Hyperhidrosis—Estradiol—osteoporosis	0.000412	0.000752	CcSEcCtD
Maprotiline—Rash—Ethinyl Estradiol—osteoporosis	0.000412	0.000752	CcSEcCtD
Maprotiline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000411	0.000751	CcSEcCtD
Maprotiline—Headache—Ethinyl Estradiol—osteoporosis	0.000409	0.000747	CcSEcCtD
Maprotiline—Vomiting—Risedronate—osteoporosis	0.000405	0.000739	CcSEcCtD
Maprotiline—Rash—Risedronate—osteoporosis	0.000402	0.000733	CcSEcCtD
Maprotiline—Dermatitis—Risedronate—osteoporosis	0.000401	0.000732	CcSEcCtD
Maprotiline—Dizziness—Pamidronate—osteoporosis	0.0004	0.000731	CcSEcCtD
Maprotiline—Headache—Risedronate—osteoporosis	0.000399	0.000728	CcSEcCtD
Maprotiline—Asthenia—Zoledronate—osteoporosis	0.000397	0.000724	CcSEcCtD
Maprotiline—Pruritus—Zoledronate—osteoporosis	0.000391	0.000714	CcSEcCtD
Maprotiline—Nausea—Ethinyl Estradiol—osteoporosis	0.000388	0.000708	CcSEcCtD
Maprotiline—Insomnia—Estradiol—osteoporosis	0.000385	0.000704	CcSEcCtD
Maprotiline—Vomiting—Pamidronate—osteoporosis	0.000385	0.000703	CcSEcCtD
Maprotiline—Paraesthesia—Estradiol—osteoporosis	0.000383	0.000698	CcSEcCtD
Maprotiline—Asthenia—Conjugated Estrogens—osteoporosis	0.000382	0.000697	CcSEcCtD
Maprotiline—Rash—Pamidronate—osteoporosis	0.000382	0.000697	CcSEcCtD
Maprotiline—Dermatitis—Pamidronate—osteoporosis	0.000381	0.000696	CcSEcCtD
Maprotiline—Headache—Pamidronate—osteoporosis	0.000379	0.000692	CcSEcCtD
Maprotiline—Somnolence—Estradiol—osteoporosis	0.000379	0.000691	CcSEcCtD
Maprotiline—Diarrhoea—Zoledronate—osteoporosis	0.000378	0.000691	CcSEcCtD
Maprotiline—Nausea—Risedronate—osteoporosis	0.000378	0.00069	CcSEcCtD
Maprotiline—Pruritus—Conjugated Estrogens—osteoporosis	0.000377	0.000688	CcSEcCtD
Maprotiline—Dyspepsia—Estradiol—osteoporosis	0.000375	0.000685	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Estradiol—osteoporosis	0.000368	0.000672	CcSEcCtD
Maprotiline—Fatigue—Estradiol—osteoporosis	0.000367	0.000671	CcSEcCtD
Maprotiline—Dizziness—Zoledronate—osteoporosis	0.000366	0.000667	CcSEcCtD
Maprotiline—Constipation—Estradiol—osteoporosis	0.000364	0.000665	CcSEcCtD
Maprotiline—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000364	0.000665	CcSEcCtD
Maprotiline—Nausea—Pamidronate—osteoporosis	0.00036	0.000656	CcSEcCtD
Maprotiline—Dizziness—Conjugated Estrogens—osteoporosis	0.000352	0.000643	CcSEcCtD
Maprotiline—Vomiting—Zoledronate—osteoporosis	0.000352	0.000642	CcSEcCtD
Maprotiline—Feeling abnormal—Estradiol—osteoporosis	0.000351	0.000641	CcSEcCtD
Maprotiline—Rash—Zoledronate—osteoporosis	0.000349	0.000636	CcSEcCtD
Maprotiline—Gastrointestinal pain—Estradiol—osteoporosis	0.000348	0.000636	CcSEcCtD
Maprotiline—Dermatitis—Zoledronate—osteoporosis	0.000348	0.000636	CcSEcCtD
Maprotiline—Headache—Zoledronate—osteoporosis	0.000346	0.000632	CcSEcCtD
Maprotiline—Vomiting—Conjugated Estrogens—osteoporosis	0.000339	0.000618	CcSEcCtD
Maprotiline—Urticaria—Estradiol—osteoporosis	0.000339	0.000618	CcSEcCtD
Maprotiline—Abdominal pain—Estradiol—osteoporosis	0.000337	0.000615	CcSEcCtD
Maprotiline—Body temperature increased—Estradiol—osteoporosis	0.000337	0.000615	CcSEcCtD
Maprotiline—Rash—Conjugated Estrogens—osteoporosis	0.000336	0.000613	CcSEcCtD
Maprotiline—Dermatitis—Conjugated Estrogens—osteoporosis	0.000335	0.000612	CcSEcCtD
Maprotiline—Headache—Conjugated Estrogens—osteoporosis	0.000334	0.000609	CcSEcCtD
Maprotiline—Nausea—Zoledronate—osteoporosis	0.000328	0.0006	CcSEcCtD
Maprotiline—Nausea—Conjugated Estrogens—osteoporosis	0.000316	0.000577	CcSEcCtD
Maprotiline—Asthenia—Estradiol—osteoporosis	0.000306	0.000558	CcSEcCtD
Maprotiline—Pruritus—Estradiol—osteoporosis	0.000301	0.00055	CcSEcCtD
Maprotiline—Diarrhoea—Estradiol—osteoporosis	0.000292	0.000532	CcSEcCtD
Maprotiline—Dizziness—Estradiol—osteoporosis	0.000282	0.000514	CcSEcCtD
Maprotiline—Vomiting—Estradiol—osteoporosis	0.000271	0.000495	CcSEcCtD
Maprotiline—Rash—Estradiol—osteoporosis	0.000269	0.00049	CcSEcCtD
Maprotiline—Dermatitis—Estradiol—osteoporosis	0.000268	0.00049	CcSEcCtD
Maprotiline—Headache—Estradiol—osteoporosis	0.000267	0.000487	CcSEcCtD
Maprotiline—Nausea—Estradiol—osteoporosis	0.000253	0.000462	CcSEcCtD
Maprotiline—CHRM2—Signaling Pathways—FGA—osteoporosis	3.67e-05	0.00032	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	3.66e-05	0.00032	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	3.65e-05	0.000319	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	3.62e-05	0.000316	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.59e-05	0.000314	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.59e-05	0.000313	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PTHLH—osteoporosis	3.53e-05	0.000308	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—BMP2—osteoporosis	3.53e-05	0.000308	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CALCA—osteoporosis	3.52e-05	0.000307	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ACP5—osteoporosis	3.5e-05	0.000305	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.5e-05	0.000305	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.49e-05	0.000304	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PTHLH—osteoporosis	3.47e-05	0.000303	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—BMP2—osteoporosis	3.47e-05	0.000303	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PTHLH—osteoporosis	3.47e-05	0.000303	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—BMP2—osteoporosis	3.47e-05	0.000303	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PTHLH—osteoporosis	3.46e-05	0.000302	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—BMP2—osteoporosis	3.46e-05	0.000302	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—FGB—osteoporosis	3.46e-05	0.000302	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TPI1—osteoporosis	3.45e-05	0.000301	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PTHLH—osteoporosis	3.45e-05	0.000301	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—BMP2—osteoporosis	3.45e-05	0.000301	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—POMC—osteoporosis	3.44e-05	0.0003	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—BMP2—osteoporosis	3.41e-05	0.000298	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PTHLH—osteoporosis	3.41e-05	0.000298	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—FGB—osteoporosis	3.4e-05	0.000297	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ADCY5—osteoporosis	3.4e-05	0.000297	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—FGB—osteoporosis	3.39e-05	0.000296	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FGB—osteoporosis	3.38e-05	0.000295	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FGB—osteoporosis	3.37e-05	0.000294	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FGB—osteoporosis	3.34e-05	0.000291	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PSMA2—osteoporosis	3.34e-05	0.000291	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PSMA5—osteoporosis	3.34e-05	0.000291	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SPP1—osteoporosis	3.29e-05	0.000287	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PSMA5—osteoporosis	3.28e-05	0.000286	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PSMA2—osteoporosis	3.28e-05	0.000286	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PSMA2—osteoporosis	3.28e-05	0.000286	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PSMA5—osteoporosis	3.28e-05	0.000286	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PSMA2—osteoporosis	3.27e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PSMA5—osteoporosis	3.27e-05	0.000285	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PSMA5—osteoporosis	3.25e-05	0.000284	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PSMA2—osteoporosis	3.25e-05	0.000284	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TPI1—osteoporosis	3.25e-05	0.000284	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—P4HB—osteoporosis	3.24e-05	0.000283	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—IDH2—osteoporosis	3.24e-05	0.000283	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PSMA2—osteoporosis	3.22e-05	0.000281	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PSMA5—osteoporosis	3.22e-05	0.000281	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ADCY5—osteoporosis	3.21e-05	0.00028	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—KL—osteoporosis	3.2e-05	0.000279	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GAPDH—osteoporosis	3.18e-05	0.000278	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—CYP19A1—osteoporosis	3.16e-05	0.000276	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—POMC—osteoporosis	3.12e-05	0.000272	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CALCA—osteoporosis	3.11e-05	0.000271	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SPP1—osteoporosis	3.11e-05	0.000271	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—RAP1A—osteoporosis	3.1e-05	0.000271	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ADCY5—osteoporosis	3.07e-05	0.000268	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CALCA—osteoporosis	3.06e-05	0.000267	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—P4HB—osteoporosis	3.06e-05	0.000267	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CALCA—osteoporosis	3.05e-05	0.000266	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.05e-05	0.000266	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6R—osteoporosis	3.04e-05	0.000266	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CALCA—osteoporosis	3.04e-05	0.000266	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CALCA—osteoporosis	3.03e-05	0.000265	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—POMC—osteoporosis	3.03e-05	0.000265	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CALCA—osteoporosis	3e-05	0.000262	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GAPDH—osteoporosis	3e-05	0.000262	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—POMC—osteoporosis	2.98e-05	0.00026	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—POMC—osteoporosis	2.98e-05	0.00026	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SPP1—osteoporosis	2.97e-05	0.00026	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IRS2—osteoporosis	2.97e-05	0.00026	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—POMC—osteoporosis	2.97e-05	0.000259	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ACP5—osteoporosis	2.96e-05	0.000259	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—POMC—osteoporosis	2.96e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—POMC—osteoporosis	2.93e-05	0.000256	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.92e-05	0.000255	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—RAP1A—osteoporosis	2.92e-05	0.000255	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—LEP—osteoporosis	2.91e-05	0.000254	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—KL—osteoporosis	2.82e-05	0.000246	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IRS2—osteoporosis	2.81e-05	0.000245	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—ESR1—osteoporosis	2.78e-05	0.000242	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—KL—osteoporosis	2.78e-05	0.000242	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—KL—osteoporosis	2.77e-05	0.000242	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—KL—osteoporosis	2.76e-05	0.000241	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—KL—osteoporosis	2.75e-05	0.00024	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TPI1—osteoporosis	2.75e-05	0.00024	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—POMC—osteoporosis	2.75e-05	0.00024	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—LEP—osteoporosis	2.75e-05	0.00024	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—KL—osteoporosis	2.73e-05	0.000238	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—POMC—osteoporosis	2.71e-05	0.000236	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—POMC—osteoporosis	2.7e-05	0.000236	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—POMC—osteoporosis	2.69e-05	0.000235	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IRS2—osteoporosis	2.69e-05	0.000235	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—POMC—osteoporosis	2.69e-05	0.000234	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6R—osteoporosis	2.69e-05	0.000234	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—POMC—osteoporosis	2.66e-05	0.000232	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6R—osteoporosis	2.64e-05	0.000231	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6R—osteoporosis	2.64e-05	0.00023	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—LEP—osteoporosis	2.63e-05	0.00023	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6R—osteoporosis	2.63e-05	0.000229	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—ESR1—osteoporosis	2.62e-05	0.000229	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6R—osteoporosis	2.62e-05	0.000229	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IRS1—osteoporosis	2.6e-05	0.000227	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6R—osteoporosis	2.6e-05	0.000226	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—P4HB—osteoporosis	2.59e-05	0.000226	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ADCY5—osteoporosis	2.58e-05	0.000225	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GPX1—osteoporosis	2.57e-05	0.000224	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GAPDH—osteoporosis	2.54e-05	0.000222	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—ESR1—osteoporosis	2.51e-05	0.000219	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ENO1—osteoporosis	2.51e-05	0.000219	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ADCY5—osteoporosis	2.51e-05	0.000219	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—POMC—osteoporosis	2.5e-05	0.000218	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—RAP1A—osteoporosis	2.48e-05	0.000216	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PSMA5—osteoporosis	2.47e-05	0.000216	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PSMA2—osteoporosis	2.47e-05	0.000216	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IRS1—osteoporosis	2.45e-05	0.000214	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6R—osteoporosis	2.44e-05	0.000213	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SPP1—osteoporosis	2.42e-05	0.000212	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF1—osteoporosis	2.4e-05	0.00021	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MTHFR—osteoporosis	2.37e-05	0.000207	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ENO1—osteoporosis	2.36e-05	0.000206	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—POMC—osteoporosis	2.36e-05	0.000206	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IRS1—osteoporosis	2.35e-05	0.000205	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PSMA5—osteoporosis	2.33e-05	0.000203	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PSMA2—osteoporosis	2.33e-05	0.000203	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6R—osteoporosis	2.3e-05	0.000201	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF1—osteoporosis	2.27e-05	0.000198	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—POMC—osteoporosis	2.26e-05	0.000197	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ADCY5—osteoporosis	2.21e-05	0.000193	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6R—osteoporosis	2.21e-05	0.000192	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IRS2—osteoporosis	2.19e-05	0.000191	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ADCY5—osteoporosis	2.18e-05	0.00019	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF1—osteoporosis	2.17e-05	0.00019	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ADCY5—osteoporosis	2.17e-05	0.000189	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ADCY5—osteoporosis	2.16e-05	0.000189	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.16e-05	0.000188	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ADCY5—osteoporosis	2.16e-05	0.000188	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—LEP—osteoporosis	2.15e-05	0.000187	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SPP1—osteoporosis	2.14e-05	0.000187	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ADCY5—osteoporosis	2.14e-05	0.000186	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SPP1—osteoporosis	2.11e-05	0.000184	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SPP1—osteoporosis	2.1e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SPP1—osteoporosis	2.09e-05	0.000183	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SPP1—osteoporosis	2.09e-05	0.000182	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SPP1—osteoporosis	2.07e-05	0.00018	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ESR1—osteoporosis	2.05e-05	0.000179	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CYP19A1—osteoporosis	2e-05	0.000175	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ENO1—osteoporosis	2e-05	0.000175	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PSMA2—osteoporosis	1.97e-05	0.000172	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PSMA5—osteoporosis	1.97e-05	0.000172	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IRS2—osteoporosis	1.93e-05	0.000169	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IRS1—osteoporosis	1.91e-05	0.000167	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IRS2—osteoporosis	1.9e-05	0.000166	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IRS2—osteoporosis	1.9e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—POMC—osteoporosis	1.9e-05	0.000166	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—LEP—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.89e-05	0.000165	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.87e-05	0.000163	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—LEP—osteoporosis	1.86e-05	0.000163	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—LEP—osteoporosis	1.86e-05	0.000162	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—LEP—osteoporosis	1.85e-05	0.000162	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—LEP—osteoporosis	1.85e-05	0.000161	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—POMC—osteoporosis	1.84e-05	0.000161	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—osteoporosis	1.84e-05	0.00016	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—LEP—osteoporosis	1.83e-05	0.00016	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ESR1—osteoporosis	1.81e-05	0.000158	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6R—osteoporosis	1.8e-05	0.000157	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ESR1—osteoporosis	1.78e-05	0.000155	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ESR1—osteoporosis	1.77e-05	0.000155	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1—osteoporosis	1.77e-05	0.000155	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ESR1—osteoporosis	1.77e-05	0.000154	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ESR1—osteoporosis	1.76e-05	0.000154	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.75e-05	0.000152	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—osteoporosis	1.74e-05	0.000152	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IRS1—osteoporosis	1.69e-05	0.000147	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—osteoporosis	1.66e-05	0.000145	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IRS1—osteoporosis	1.66e-05	0.000145	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IRS1—osteoporosis	1.66e-05	0.000145	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IRS1—osteoporosis	1.65e-05	0.000144	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IRS1—osteoporosis	1.65e-05	0.000144	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ADCY5—osteoporosis	1.64e-05	0.000143	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.63e-05	0.000142	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GPX1—osteoporosis	1.63e-05	0.000142	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—osteoporosis	1.63e-05	0.000142	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—osteoporosis	1.6e-05	0.00014	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.6e-05	0.00014	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—osteoporosis	1.6e-05	0.000139	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—osteoporosis	1.59e-05	0.000139	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—osteoporosis	1.59e-05	0.000138	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6R—osteoporosis	1.59e-05	0.000138	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—osteoporosis	1.57e-05	0.000137	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—osteoporosis	1.56e-05	0.000137	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6R—osteoporosis	1.56e-05	0.000136	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6R—osteoporosis	1.56e-05	0.000136	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.55e-05	0.000136	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6R—osteoporosis	1.55e-05	0.000135	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ADCY5—osteoporosis	1.54e-05	0.000135	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—osteoporosis	1.54e-05	0.000134	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX1—osteoporosis	1.54e-05	0.000134	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—osteoporosis	1.54e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.53e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—osteoporosis	1.53e-05	0.000134	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—osteoporosis	1.53e-05	0.000133	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.51e-05	0.000132	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—osteoporosis	1.51e-05	0.000131	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MYC—osteoporosis	1.45e-05	0.000126	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—osteoporosis	1.44e-05	0.000126	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—osteoporosis	1.42e-05	0.000124	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MYC—osteoporosis	1.36e-05	0.000119	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—osteoporosis	1.36e-05	0.000119	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—osteoporosis	1.36e-05	0.000118	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MYC—osteoporosis	1.31e-05	0.000114	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ADCY5—osteoporosis	1.31e-05	0.000114	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—osteoporosis	1.3e-05	0.000114	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX1—osteoporosis	1.3e-05	0.000114	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—osteoporosis	1.2e-05	0.000105	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—osteoporosis	1.2e-05	0.000105	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—osteoporosis	1.2e-05	0.000104	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—osteoporosis	1.18e-05	0.000103	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—osteoporosis	1.17e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—osteoporosis	1.17e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—osteoporosis	1.17e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—osteoporosis	1.16e-05	0.000101	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—osteoporosis	1.13e-05	9.9e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—osteoporosis	1.09e-05	9.48e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MYC—osteoporosis	1.07e-05	9.3e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—osteoporosis	1.06e-05	9.28e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—osteoporosis	1.03e-05	8.95e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—osteoporosis	9.83e-06	8.57e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—osteoporosis	9.61e-06	8.39e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MYC—osteoporosis	9.4e-06	8.21e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—osteoporosis	9.38e-06	8.19e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MYC—osteoporosis	9.25e-06	8.07e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MYC—osteoporosis	9.23e-06	8.06e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—osteoporosis	9.23e-06	8.05e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—osteoporosis	9.21e-06	8.04e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MYC—osteoporosis	9.2e-06	8.03e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—osteoporosis	9.18e-06	8.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MYC—osteoporosis	9.17e-06	8.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—osteoporosis	9.15e-06	7.99e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MYC—osteoporosis	9.08e-06	7.93e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—osteoporosis	9.06e-06	7.91e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—osteoporosis	8.01e-06	6.99e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—osteoporosis	7.07e-06	6.17e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—osteoporosis	6.96e-06	6.07e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—osteoporosis	6.94e-06	6.06e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—osteoporosis	6.92e-06	6.04e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—osteoporosis	6.9e-06	6.02e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—osteoporosis	6.83e-06	5.96e-05	CbGpPWpGaD
